• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童肌肉注射免疫球蛋白预防麻疹的临床经验:是否可行?

Clinical experience of intramuscular immunoglobulin for measles prophylaxis in children: Is it practical?

作者信息

Philips Leanne, Young Megan K, Wallace Janet, Dobinson Hazel C

机构信息

Children's Health Queensland, Queensland Children's Hospital, Brisbane, Queensland, Australia.

School of Nursing, Midwifery and Social Work, University of Queensland, Brisbane, Queensland, Australia.

出版信息

J Paediatr Child Health. 2020 Mar;56(3):364-366. doi: 10.1111/jpc.14800. Epub 2020 Feb 11.

DOI:10.1111/jpc.14800
PMID:32043701
Abstract

Measles continues to be a public health concern world-wide. Vulnerable individuals including those in which vaccinations is contraindicated, may be reliant on normal human immunoglobulin (NHIG) prophylaxis in an aim to prevent disease. This paper will summarise and discuss a tertiary paediatric hospital's clinical experience and the practicalities of administering intramuscular (IM) NHIG to paediatric patients as per the current measles prophylaxis guidelines in Australia. Following potential exposure within the emergency department, 17 paediatric patients (0-15 years) were recommended IM NHIG for prophylaxis. The dose of NHIG ranged from 0.6 to 15 mL and required multiple (2-8) injections. Two patients required sedation for staff to safely administer the injections. Staff involved with these cases reported administering multiple injections to paediatric patients to be a traumatising experience. They also expressed views that the injection of large volumes via the IM route was an impractical method of administration. Based on this experience, we recommend intravenous immunoglobulin be considered when large volumes of NHIG are recommended intramuscularly.

摘要

麻疹仍是全球公共卫生关注的问题。包括那些禁忌接种疫苗的弱势群体,可能依赖于注射正常人免疫球蛋白(NHIG)来预防疾病。本文将总结并讨论一家三级儿科医院的临床经验,以及按照澳大利亚当前麻疹预防指南给儿科患者肌内注射NHIG的实际情况。在急诊科有潜在暴露风险后,17名儿科患者(0至15岁)被建议肌内注射NHIG进行预防。NHIG的剂量为0.6至15毫升,需要多次(2至8次)注射。两名患者需要镇静以便工作人员安全地进行注射。参与这些病例的工作人员报告说,给儿科患者多次注射是一次痛苦的经历。他们还表示,通过肌内途径注射大量药物是一种不切实际的给药方法。基于这一经验,我们建议当建议大量肌内注射NHIG时,考虑使用静脉注射免疫球蛋白。

相似文献

1
Clinical experience of intramuscular immunoglobulin for measles prophylaxis in children: Is it practical?儿童肌肉注射免疫球蛋白预防麻疹的临床经验:是否可行?
J Paediatr Child Health. 2020 Mar;56(3):364-366. doi: 10.1111/jpc.14800. Epub 2020 Feb 11.
2
The use of normal human immunoglobulin (NHIG) for public health purposes in Queensland 2004-2014 and Australia 2014-2016.2004 - 2014年在昆士兰州以及2014 - 2016年在澳大利亚将正常人免疫球蛋白(NHIG)用于公共卫生目的的情况。
Commun Dis Intell (2018). 2019 Mar 15;43. doi: 10.33321/cdi.2019.43.9.
3
A Cross-Sectional Study of Measles-Specific Antibody Levels in Australian Blood Donors-Implications for Measles Post-Elimination Countries.澳大利亚献血者中麻疹特异性抗体水平的横断面研究——对麻疹消除后国家的启示
Vaccines (Basel). 2024 Jul 22;12(7):818. doi: 10.3390/vaccines12070818.
4
Estimated protective effectiveness of intramuscular immune serum globulin post-exposure prophylaxis during a measles outbreak in British Columbia, Canada, 2014.2014年加拿大不列颠哥伦比亚省麻疹疫情期间,暴露后预防使用肌内免疫血清球蛋白的估计保护效果。
Vaccine. 2017 May 9;35(20):2723-2727. doi: 10.1016/j.vaccine.2017.03.069. Epub 2017 Apr 6.
5
The optimal dose of disease-specific antibodies for post-exposure prophylaxis of measles and rubella in Australia: new guidelines recommended.澳大利亚推荐了新的指南,用于确定麻疹和风疹暴露后预防的疾病特异性抗体的最佳剂量。
Expert Opin Drug Metab Toxicol. 2018 Jul;14(7):663-669. doi: 10.1080/17425255.2018.1484449.
6
Immunogenicity and safety of intramuscular versus subcutaneous administration of a combined measles, mumps, rubella, and varicella vaccine to children 12 to 18 months of age.12 至 18 月龄儿童肌内与皮下接种麻疹、腮腺炎、风疹和水痘联合疫苗的免疫原性和安全性。
Hum Vaccin Immunother. 2019;15(4):778-785. doi: 10.1080/21645515.2018.1549452. Epub 2019 Jan 8.
7
Do Australian immunoglobulin products meet international measles antibody titer standards?澳大利亚的免疫球蛋白产品是否符合国际麻疹抗体滴度标准?
Hum Vaccin Immunother. 2017 Mar 4;13(3):607-612. doi: 10.1080/21645515.2016.1234554. Epub 2016 Oct 20.
8
The effect of human immunodeficiency virus-1 infection and stunting on measles immunoglobulin-G levels in children vaccinated against measles in Uganda.人类免疫缺陷病毒1型感染和发育迟缓对乌干达接种麻疹疫苗儿童麻疹免疫球蛋白G水平的影响。
Int J Epidemiol. 1999 Apr;28(2):341-6. doi: 10.1093/ije/28.2.341.
9
Post-exposure prophylaxis for measles with immunoglobulins revised recommendations of the standing committee on vaccination in Germany.接触后用免疫球蛋白预防麻疹——德国疫苗接种常设委员会的修订建议。
Vaccine. 2018 Dec 18;36(52):7916-7922. doi: 10.1016/j.vaccine.2018.10.070. Epub 2018 Nov 23.
10
Needle size for vaccination procedures in children and adolescents.儿童和青少年疫苗接种程序的针头尺寸。
Cochrane Database Syst Rev. 2015 Jun 18(6):CD010720. doi: 10.1002/14651858.CD010720.pub2.